Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holger Amthauer

Showing results (71-80 of 204) with videos related to

Pageof 21
Sort By:
Maturitas|December 27, 2011
Serum cathepsin K levels are not suitable to differentiate women with chronic bone disorders such as osteopenia and osteoporosis from healthy pre- and postmenopausal womenDaniela Adolf, Thomas Wex, Oliver Jahn, et al.
Molecular and Clinical Oncology|December 28, 2020
A rare case of a patient with a high grade neuroendocrine tumor developing neutropenic sepsis after receiving PRRT combined with Capecitabine or Temozolomide: A case reportBurcin Özdirik, Holger Amthauer, Imke Schatka, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 12, 2014
Safety of repeated radioembolizations in patients with advanced primary and secondary liver tumors and progressive disease after first selective internal radiotherapyAlina Zarva, Konrad Mohnike, Robert Damm, et al.
EJNMMI Research|March 23, 2023
Same same but different: dopamine transporter SPECT on scanners with CZT vs. NaI detectorsFelix Thiele, Franziska Schau, Julian M M Rogasch, et al.
European Radiology|March 1, 2022
Yttrium-90 radioembolization for unresectable hepatocellular carcinoma: predictive modeling strategies to anticipate tumor response and improve patient selectionWillie Lüdemann, Johannes Kahn, Daniel Pustelnik, et al.
Clinical Nuclear Medicine|March 22, 2006
Relevance of image fusion with MRI for the interpretation of I-123 iodo-methyl-tyrosine scans in patients with suspected recurrent or residual brain tumorHolger Amthauer, Reinhard Wurm, David Kuczer, et al.
Gastroenterology Research and Practice|March 12, 2016
Extensive Use of Interventional Therapies Improves Survival in Unresectable or Recurrent Intrahepatic CholangiocarcinomaRicarda Seidensticker, Max Seidensticker, Kathleen Doegen, et al.
EJNMMI Research|October 22, 2013
Explorative analyses on the value of interim PET for prediction of response in pediatric and adolescent non-Hodgkin lymphoma patientsChristian Furth, Ingo G Steffen, Anne S Erdrich, et al.
Cardiovascular and Interventional Radiology|March 12, 2017
Cytokines and <sup>90</sup>Y-Radioembolization: Relation to Liver Function and Overall SurvivalMax Seidensticker, Maciej Powerski, Ricarda Seidensticker, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 10, 2004
Retrospective digital image fusion of multidetector CT and 18F-FDG PET: clinical value in pancreatic lesions--a prospective study with 104 patientsArne-Jörn Lemke, Stefan Markus Niehues, Norbert Hosten, et al.
Pageof 21

Showing results (71-80 of 204) with videos related to

Sort By:
Pageof 21
Maturitas|December 27, 2011
Serum cathepsin K levels are not suitable to differentiate women with chronic bone disorders such as osteopenia and osteoporosis from healthy pre- and postmenopausal womenDaniela Adolf, Thomas Wex, Oliver Jahn, et al.
Molecular and Clinical Oncology|December 28, 2020
A rare case of a patient with a high grade neuroendocrine tumor developing neutropenic sepsis after receiving PRRT combined with Capecitabine or Temozolomide: A case reportBurcin Özdirik, Holger Amthauer, Imke Schatka, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 12, 2014
Safety of repeated radioembolizations in patients with advanced primary and secondary liver tumors and progressive disease after first selective internal radiotherapyAlina Zarva, Konrad Mohnike, Robert Damm, et al.
EJNMMI Research|March 23, 2023
Same same but different: dopamine transporter SPECT on scanners with CZT vs. NaI detectorsFelix Thiele, Franziska Schau, Julian M M Rogasch, et al.
European Radiology|March 1, 2022
Yttrium-90 radioembolization for unresectable hepatocellular carcinoma: predictive modeling strategies to anticipate tumor response and improve patient selectionWillie Lüdemann, Johannes Kahn, Daniel Pustelnik, et al.
Clinical Nuclear Medicine|March 22, 2006
Relevance of image fusion with MRI for the interpretation of I-123 iodo-methyl-tyrosine scans in patients with suspected recurrent or residual brain tumorHolger Amthauer, Reinhard Wurm, David Kuczer, et al.
Gastroenterology Research and Practice|March 12, 2016
Extensive Use of Interventional Therapies Improves Survival in Unresectable or Recurrent Intrahepatic CholangiocarcinomaRicarda Seidensticker, Max Seidensticker, Kathleen Doegen, et al.
EJNMMI Research|October 22, 2013
Explorative analyses on the value of interim PET for prediction of response in pediatric and adolescent non-Hodgkin lymphoma patientsChristian Furth, Ingo G Steffen, Anne S Erdrich, et al.
Cardiovascular and Interventional Radiology|March 12, 2017
Cytokines and <sup>90</sup>Y-Radioembolization: Relation to Liver Function and Overall SurvivalMax Seidensticker, Maciej Powerski, Ricarda Seidensticker, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 10, 2004
Retrospective digital image fusion of multidetector CT and 18F-FDG PET: clinical value in pancreatic lesions--a prospective study with 104 patientsArne-Jörn Lemke, Stefan Markus Niehues, Norbert Hosten, et al.
Pageof 21